How to Negotiate Cell & Gene Therapy Contracts with German Treatment Centers – Trends in Cell, Tissue, and Gene Therapies

Start
For autologous cell and gene therapies (CGTs), the collection of patients‘ cells is the first step in the manufacture of the medicinal product. In Germany, this step is usually conducted by specialized treatment centers that have their own cell collection unit and thus handle both the cell collection as well as the later storage, handling, and administration of the finished drug product….
By: Hogan Lovells
Previous Story

From Vulnerability to Violation: FDA Cybersecurity Requirements for Medical Devices and FCA Enforcement

Next Story

5 Things You Should Know Before Adopting AI in the UK